Brief: Stoke Therapeutics Appoints Director Ian F. Smith Interim Chief Executive Officer
18/03/2025 10:59
March 18 (Reuters) - Stoke Therapeutics Inc STOK.O: STOKE THERAPEUTICS INC: DIRECTOR IAN F. SMITH APPOINTED INTERIM CHIEF EXECUTIVE OFFICER STOKE THERAPEUTICS INC: ARTHUR TZIANABOS APPOINTED INTERIM EXECUTIVE CHAIRMAN OF BOARD STOKE THERAPEUTICS INC: EDWARD M. KAYE TO STEP DOWN AS CHIEF EXECUTIVE OFFICER Source text: ID:nBw3BSwcma Further company coverage: STOK.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Stoke Therapeutics
See all newsBrief: Stoke Therapeutics Announces Inducement Grants
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics